154 related articles for article (PubMed ID: 33327259)
1. Computational study on natural compounds inhibitor of c-Myc.
Ren J; Huangfu Y; Ge J; Wu B; Li W; Wang X; Zhao L
Medicine (Baltimore); 2020 Dec; 99(50):e23342. PubMed ID: 33327259
[TBL] [Abstract][Full Text] [Related]
2. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
[TBL] [Abstract][Full Text] [Related]
3. Computational Study of Novel Natural Inhibitors Targeting O
Yang L; Li W; Zhao Y; Zhong S; Wang X; Jiang S; Cheng Y; Xu H; Zhao G
World Neurosurg; 2019 Oct; 130():e294-e306. PubMed ID: 31203065
[TBL] [Abstract][Full Text] [Related]
4. Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).
Ge J; Wang Z; Cheng Y; Ren J; Wu B; Li W; Wang X; Su X; Liu Z
Aging (Albany NY); 2020 May; 12(9):8523-8535. PubMed ID: 32388498
[TBL] [Abstract][Full Text] [Related]
5. Novel natural inhibitors targeting B-RAF(V600E) by computational study.
Wu B; Zhang Z; Dou G; Lv X; Ge J; Wang H; Xie H; Zhu D
Bioengineered; 2021 Dec; 12(1):2970-2983. PubMed ID: 34252351
[TBL] [Abstract][Full Text] [Related]
6. Novel natural inhibitors targeting KRAS G12C by computational study.
Jiang Y; Chen W; Wang X; Zhou B; Xie H; Hou Y; Guo Z; Yu B; Zhong S; Su X
Anticancer Drugs; 2022 Oct; 33(9):779-788. PubMed ID: 35980001
[TBL] [Abstract][Full Text] [Related]
7. Computational study on novel natural inhibitors targeting c-MET.
Hou Y; Xie H; Dou G; Yang W; Ge J; Zhou B; Ren J; Li J; Wang J; Zhang Z; Wang X
Medicine (Baltimore); 2021 Sep; 100(38):e27171. PubMed ID: 34559105
[TBL] [Abstract][Full Text] [Related]
8. Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study.
Zhong S; Wu B; Yang W; Ge J; Zhang X; Chen Z; Duan H; He Z; Liu Y; Wang H; Jiang Y; Zhang Z; Wang X; Li W; Liu N; Guo X; Mou Y
Aging (Albany NY); 2021 Jan; 13(2):1898-1912. PubMed ID: 33486472
[TBL] [Abstract][Full Text] [Related]
9. Computational study on novel natural inhibitors targeting BCL2.
Lv X; Jiang Y; Wang X; Xie H; Dou G; Wang J; Yang W; Wang H; Li Z; Zhang X; Chen Z
Med Oncol; 2021 Jul; 38(8):94. PubMed ID: 34259934
[TBL] [Abstract][Full Text] [Related]
10. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
Yang X; Fan D; Troha AH; Ahn HM; Qian K; Liang B; Du Y; Fu H; Ivanov AA
Bioorg Med Chem; 2021 Sep; 45():116324. PubMed ID: 34333394
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
Harikrishna S; Kotaru S; Pradeepkumar PI
Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer.
Carabet LA; Lallous N; Leblanc E; Ban F; Morin H; Lawn S; Ghaidi F; Lee J; Mills IG; Gleave ME; Rennie PS; Cherkasov A
Eur J Med Chem; 2018 Dec; 160():108-119. PubMed ID: 30326371
[TBL] [Abstract][Full Text] [Related]
13. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches.
Carabet LA; Rennie PS; Cherkasov A
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597997
[TBL] [Abstract][Full Text] [Related]
15. Identification of inhibitors targeting HIF-2α/c-Myc by molecular docking and MM-GBSA technology.
Feng L; Sun C; Sun X; Zhao Y; Yu R; Kang C
J Recept Signal Transduct Res; 2021 Oct; 41(5):511-519. PubMed ID: 32981413
[TBL] [Abstract][Full Text] [Related]
16. New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high-grade glioma therapy.
Yang W; Wang S; Zhang X; Sun H; Zhang M; Chen H; Cui J; Li J; Peng F; Zhu M; Yu B; Li Y; Yang L; Min W; Xue M; Pan L; Zhu H; Wu B; Gu Y
Front Neurosci; 2022; 16():1060012. PubMed ID: 36685223
[TBL] [Abstract][Full Text] [Related]
17. Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9.
Zhao Y; Li W; Li W; Tao H; Li Y; Wu B; Wang X; Zhou H; Gao B
Biomed Res Int; 2022; 2022():9039377. PubMed ID: 36267835
[TBL] [Abstract][Full Text] [Related]
18. Structure-based Inhibitor Design for the Intrinsically Disordered Protein c-Myc.
Yu C; Niu X; Jin F; Liu Z; Jin C; Lai L
Sci Rep; 2016 Mar; 6():22298. PubMed ID: 26931396
[TBL] [Abstract][Full Text] [Related]
19. Selected by bioinformatics and molecular docking analysis, Dhea and 2-14,15-Eg are effective against cholangiocarcinoma.
Qin L; Kuai J; Yang F; Yang L; Sun P; Zhang L; Li G
PLoS One; 2022; 17(2):e0260180. PubMed ID: 35113866
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
